Peer Exchange Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.
All Peer Exchange Expanding Treatment Options for Metastatic Breast Cancer COPD Treatment Updates: Impact on Daily Life A Deeper Understanding of Wound Care Understanding the Comorbidities: Psoriasis and Metabolic Syndrome Managing Challenges of Insomnia in Elderly Patients The Challenges and Treatment of Sickle Cell Disease Identifying Secondary Progressive Multiple Sclerosis A Review of the Treatment for Multiple Myeloma Rare Neurological Diseases: Spinal Muscular Atrophy and Huntington's Disease An Introduction of a New Class for the Treatment of Bone Health An Overview of the Value-Based Marketplace The Progression of Type 2 Diabetes and the Treatment Options to Manage It Immunotherapy in the Oncology Care Model Preventive Treatments for Migraines The Use of Biologics for the Treatment of Asthma Improved Outcomes in the Management of Hepatic Encephalopathy Expert Perspectives on Schizophrenia Treatment Approaches and Relapse Prevention Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer Oncology Stakeholders Summit, Summer 2018 Emerging Treatment for Migraine Advances in the Treatment of Hyperhidrosis Special Considerations in HIV Management Finding Value in Today's New Insulin Technology in Diabetes Care: From Prevention to Disease Management
Age-Related Macular Degeneration Treatments: Determining Appropriate Use Diabetes Therapy and Cardiovascular Outcomes: An Update Oncology Stakeholders Summit, Spring 2017 Reducing CVD Risk Through Optimal Lipid Management Oncology Stakeholders Summit, Fall 2016 Management Optimization in Atopic Dermatitis Oral Oncolytics: Exploring Challenges in Cost, Adherence, and Management Reducing Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus Oncology Stakeholders Summit, Spring 2016 Diabetes-Related Complications: A Focus on Diabetic Macular Edema Oncology Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit 2014 Diabetes and Obesity Management Prostate Cancer Rare Disease Neurological Disorders Immunotherapy Diabetes and Cardiometabolic Health
May 13, 2020 –
Typical outcomes for patients who have progressed after 2 lines of therapy in HER2+ metastatic breast cancer and a review of trastuzumab deruxtecan as seen in the DESTINY-Breast01 trial.
May 13, 2020 –
A payer perspective on coverage of IV versus oral therapy in metastatic breast cancer taking into consideration cost and patient survival outcomes.
May 06, 2020 –
The importance of patient education in managing toxicities on therapy in metastatic breast cancer.
May 06, 2020 –
A discussion on a phase 3 trial using oral paclitaxel and encequidar for treatment of metastatic breast cancer.
April 29, 2020 –
Testing patients who have received CDK4/6 inhibitors in metastatic breast cancer as well as testing patients with ctDNA upon disease progression with a single gene test versus NGS.
April 29, 2020 –
The role of PI3 kinase inhibition in various settings in metastatic breast cancer and a payer perspective on differentiating breast cancer at various stages of disease progression.
April 22, 2020 –
The SOLAR-1 trial data in the second-line setting in metastatic breast cancer are examined as well as the use of alpelisib and everolimus.
April 22, 2020 –
Testing for ESR1 mutations after disease progression in metastatic breast cancer.
March 11, 2020 –
Implications for treating chronic obstructive pulmonary disease with combination regimens based on clinical data and how the condition will likely be managed in the coming years.
March 04, 2020 –
The role of assessing and measuring patients’ feedback to improve how chronic obstructive pulmonary disease is managed.
